131 related articles for article (PubMed ID: 2391702)
1. 1-(aminoalkyl)-2-phenylindoles as novel pure estrogen antagonists.
von Angerer E; Knebel N; Kager M; Ganss B
J Med Chem; 1990 Sep; 33(9):2635-40. PubMed ID: 2391702
[TBL] [Abstract][Full Text] [Related]
2. 2-Phenylindoles with sulfur containing side chains. Estrogen receptor affinity, antiestrogenic potency, and antitumor activity.
Biberger C; von Angerer E
J Steroid Biochem Mol Biol; 1996 Apr; 58(1):31-43. PubMed ID: 8809184
[TBL] [Abstract][Full Text] [Related]
3. 1-Carbamoylalkyl-2-phenylindoles: relationship between side chain structure and estrogen antagonism.
von Angerer E; Biberger C; Holler E; Koop R; Leichtl S
J Steroid Biochem Mol Biol; 1994 May; 49(1):51-62. PubMed ID: 8003439
[TBL] [Abstract][Full Text] [Related]
4. 2-Phenylindoles. Effect of N-benzylation on estrogen receptor affinity, estrogenic properties, and mammary tumor inhibiting activity.
von Angerer E; Strohmeier J
J Med Chem; 1987 Jan; 30(1):131-6. PubMed ID: 3806590
[TBL] [Abstract][Full Text] [Related]
5. 6-Alkyl-12-formylindolo[2,1-a]isoquinolines. Syntheses, estrogen receptor binding affinities, and stereospecific cytostatic activity.
Polossek T; Ambros R; von Angerer S; Brandl G; Mannschreck A; von Angerer E
J Med Chem; 1992 Sep; 35(19):3537-47. PubMed ID: 1404234
[TBL] [Abstract][Full Text] [Related]
6. 3-Alkyl-2-phenylbenzo[b]thiophenes: nonsteroidal estrogen antagonists with mammary tumor inhibiting activity.
von Angerer E; Erber S
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):557-62. PubMed ID: 1562527
[TBL] [Abstract][Full Text] [Related]
7. Ring-substituted 1,1,2,2-tetraalkylated 1,2-bis(hydroxyphenyl)ethanes. 4. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of symmetrically disubstituted 1,1,2,2-tetramethyl-1,2-bis(hydroxyphenyl)ethanes.
Hartmann RW; Schwarz W; Heindl A; Schönenberger H
J Med Chem; 1985 Sep; 28(9):1295-301. PubMed ID: 2993619
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship of antiestrogens. Effect of the side chain and its position on the activity of 2,3-diaryl-2H-1-benzopyrans.
Sharma AP; Saeed A; Durani S; Kapil RS
J Med Chem; 1990 Dec; 33(12):3216-22. PubMed ID: 2258907
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship of antiestrogens. Studies on 2,3-diaryl-1-benzopyrans.
Saeed A; Sharma AP; Durani N; Jain R; Durani S; Kapil RS
J Med Chem; 1990 Dec; 33(12):3210-6. PubMed ID: 2258906
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure guided evaluation of estrogen agonist and antagonist activities of some new tetrazolyl indole derivatives.
Singh US; Shankar R; Yadav GP; Kharkwal G; Dwivedi A; Keshri G; Singh MM; Moulik PR; Hajela K
Eur J Med Chem; 2008 Oct; 43(10):2149-58. PubMed ID: 18155810
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship of antiestrogens: a study using triarylbutenone, benzofuran, and triarylfuran analogues as models for triarylethylenes and triarylpropenones.
Durani N; Jain R; Saeed A; Dikshit DK; Durani S; Kapil RS
J Med Chem; 1989 Aug; 32(8):1700-7. PubMed ID: 2754694
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and estrogen receptor affinity of 2,3-diarylindoles.
Strohmeier J; von Angerer E
Arch Pharm (Weinheim); 1987 May; 320(5):407-17. PubMed ID: 3606350
[No Abstract] [Full Text] [Related]
13. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxy or counterpart function with the estrogen receptor.
Borgna JL; Scali J
Eur J Biochem; 1991 Aug; 199(3):575-85. PubMed ID: 1868844
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifene.
Grese TA; Cho S; Finley DR; Godfrey AG; Jones CD; Lugar CW; Martin MJ; Matsumoto K; Pennington LD; Winter MA; Adrian MD; Cole HW; Magee DE; Phillips DL; Rowley ER; Short LL; Glasebrook AL; Bryant HU
J Med Chem; 1997 Jan; 40(2):146-67. PubMed ID: 9003514
[TBL] [Abstract][Full Text] [Related]
15. 2-Phenylindoles. Relationship between structure, estrogen receptor affinity, and mammary tumor inhibiting activity in the rat.
von Angerer E; Prekajac J; Strohmeier J
J Med Chem; 1984 Nov; 27(11):1439-47. PubMed ID: 6492074
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship of antiestrogens. Phenolic analogues of 2,3-diaryl-2H-1-benzopyrans.
Sharma AP; Saeed A; Durani S; Kapil RS
J Med Chem; 1990 Dec; 33(12):3222-9. PubMed ID: 2258908
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of new halo-steroidal antiestrogens.
Levesque C; Merand Y; Dufour JM; Labrie C; Labrie F
J Med Chem; 1991 May; 34(5):1624-30. PubMed ID: 2033587
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the uterotropic activity of estrogens and antiestrogens by the short acting antiestrogen LY117018.
Jordan VC; Gosden B
Endocrinology; 1983 Aug; 113(2):463-8. PubMed ID: 6872937
[TBL] [Abstract][Full Text] [Related]
19. 1-Benzyl-2-phenylindole- and 1,2-diphenylindole-based antiestrogens. Estimation of agonist and antagonist activities in transfection assays.
Biberger C; von Angerer E
J Steroid Biochem Mol Biol; 1998 Mar; 64(5-6):277-85. PubMed ID: 9618029
[TBL] [Abstract][Full Text] [Related]
20. Influence of alkyl chain ramification on estradiol receptor binding affinity and intrinsic activity of 1,2-dialkylated 1,2-bis(4- or 3-hydroxyphenyl)ethane estrogens and antiestrogens.
Hartmann RW
J Med Chem; 1986 Sep; 29(9):1668-74. PubMed ID: 3018243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
